BLRX logo

BioLineRx Ltd. (BLRX)

Profile

Full Name

BioLineRx Ltd.

Ticker

NASDAQ: BLRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Israel

IPO

July 27, 2011

Indexes

Not included

Website

https://www.biolinerx.com

Employees

28

Key Details

Price

$3.33(3.74%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$28.94M(502.92% YoY)

Annual EPS

-$4.62(-389.51% YoY)

PE Ratio

-

Next earnings date

Nov 24, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.33
    BLRX price is $3.33

    30-Day Relative Volume

    1.75
    BLRX 30-day relative volume is 1.75

    Price Performance

    Price Most Recent Change

    +3.74%
    BLRX price was up +3.74% on Nov 19, 2025

    Price YTD Change

    -60.36%
    BLRX price is down -60.36% since January 1st

    Price 1-Year Change

    -84.58%
    BLRX price is down -84.58% year-on-year

    Price 3-Year Change

    -87.76%
    BLRX price is down -87.76% over the past 3 years

    Price Range

    Price All-Time High

    $4122.00
    BLRX price is currently -99.92% below its historical high of $4122.00

    Price 3-Year Low

    $2.30
    BLRX price is currently +44.78% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $14.19M
    BLRX market cap is $14.19 million

    Market Cap 3-Year Change

    -66.07%
    BLRX market cap is down -66.07% over the past 3 years

    Market Cap All-Time High

    $210.00M
    BLRX market cap is currently -93.24% below its historical high of $210.00 million

    Market Cap Sector Percentile

    20.33%
    BLRX market cap is higher than 20.33% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +113.16%
    BLRX shares outstanding is up +113.16% year-on-year

    Shares Outstanding 3-Year Change

    +177.14%
    BLRX shares outstanding is up +177.14% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.88
    BLRX beta is 0.88

    200-day SMA

    $3.73
    BLRX price is currently -10.75% below its 200-day simple moving average

    50-day SMA

    $3.72
    BLRX price is currently -10.43% below its 50-day simple moving average

    14-Day RSI

    44.09
    BLRX 14-day relative strength index is 44.09

    Volume

    1.75
    BLRX 30-day relative volume is 1.75

    ATR

    $0.23
    BLRX average true range is $0.23

    10-day Historical Volatility

    72.62%
    BLRX 10-day historical volatility is 72.62%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $28.94M
    BLRX annual revenue is $28.94 million

    Revenue Analysts Estimate

    $2.01M
    BLRX annual revenue is currently +1341.00% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    +502.92%
    BLRX annual revenue is up +502.92% year-on-year

    Revenue Sector Percentile

    56.6%
    BLRX annual revenue is higher than 56.6% of companies in Healthcare sector

    EPS

    EPS

    -$4.62
    BLRX annual earnings per share is -$4.62

    EPS Analysts Estimate

    -$0.80
    BLRX annual earnings per share is currently -481.13% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -389.51%
    BLRX annual earnings per share is down -389.51% year-on-year

    EPS Sector Percentile

    22.14%
    BLRX annual earnings per share is higher than 22.14% of companies in Healthcare sector

    Profit

    Gross Profit

    $18.91M
    BLRX annual gross profit is $18.91 million

    Gross Margin

    65.33%
    BLRX annual gross profit margin is 65.33%

    Operating Profit

    -$19.40M
    BLRX annual operating income is -$19.40 million

    Operating Margin

    -67.03%
    BLRX annual operating profit margin is -67.03%

    Net Income

    -$9.22M
    BLRX annual net profit is -$9.22 million

    Net Margin

    -31.86%
    BLRX annual net profit margin is -31.86%

    Expenses

    Total Expenses

    $38.16M
    BLRX annual total expenses is $38.16 million

    Operating Expenses

    $38.30M
    BLRX annual total operating expenses is $38.30 million

    Cost Of Goods Sold

    $10.03M
    BLRX annual cost of goods sold is $10.03 million

    Selling, General & Administrative Expenses

    $0.00
    BLRX annual SG&A is $0.00

    Depreciation & Amortization

    $4.07M
    BLRX annual D&A is $4.07 million

    Interest Expense

    $0.00
    BLRX annual interest expense is $0.00

    Income Tax

    $0.00
    BLRX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$19.40M
    BLRX annual earnings before interest & taxes is -$19.40 million

    EBITDA

    -$15.30M
    BLRX annual EBITDA is -$15.30 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $38.91M
    BLRX annual total assets is $38.91 million

    Non Current Assets

    $11.80M
    BLRX annual long term assets is $11.80 million

    Current Assets

    $27.10M
    BLRX annual total current assets is $27.10 million

    Cash and Cash Equivalents

    $19.56M
    BLRX annual cash & cash equivalents is $19.56 million

    Accounts Receivable

    $2.48M
    BLRX annual accounts receivable is $2.48 million

    Inventory

    $3.15M
    BLRX annual inventory is $3.15 million

    Liabilities

    Total Liabilities

    $25.45M
    BLRX annual total liabilities is $25.45 million

    Long Term Liabilities

    $10.04M
    BLRX annual total long term liabilities is $10.04 million

    Current Liabilities

    $15.41M
    BLRX annual current liabilities is $15.41 million

    Accounts Payable

    $5.58M
    BLRX annual accounts payable is $5.58 million

    Debt

    Total Debt

    $15.04M
    BLRX annual total debt is $15.04 million

    Total Debt 1-Year Change

    +29.76%
    BLRX annual total debt is up +29.76% year-on-year

    Long Term Debt

    $10.04M
    BLRX annual long term debt is $10.04 million

    Short Term Debt

    $5.00M
    BLRX annual short term debt is $5.00 million

    Equity & Capital

    Shareholders Equity

    $13.46M
    BLRX annual stockholders equity is $13.46 million

    Book Value

    $13.46M
    BLRX annual book value is $13.46 million

    Retained Earnings

    -$399.83M
    BLRX annual retained earnings is -$399.83 million

    Working Capital

    $11.70M
    BLRX annual working capital is $11.70 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$43.87M
    BLRX annual cash from operations is -$43.87 million

    Cash From Operations 1-Year Change

    -94.06%
    BLRX annual cash from operations is down -94.06% year-on-year

    Cash From Investing

    $29.37M
    BLRX annual cash from investing is $29.37 million

    Cash From Investing 1-Year Change

    +1934.21%
    BLRX annual cash from investing is up +1934.21% year-on-year

    Cash From Financing

    $20.66M
    BLRX annual cash from financing is $20.66 million

    Cash From Financing 1-Year Change

    +37.21%
    BLRX annual cash from financing is up +37.21% year-on-year

    CAPEX

    CAPEX

    $54.00K
    BLRX annual capital expenditures is $54.00 thousand

    CAPEX 1-Year Change

    -81.82%
    BLRX annual capital expenditures is down -81.82% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$43.93M
    BLRX annual free cash flow is -$43.93 million

    Free Cash Flow 1-Year Change

    -91.78%
    BLRX annual free cash flow is down -91.78% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    65.33%
    BLRX annual gross profit margin is 65.33%

    Operating Margin

    -67.03%
    BLRX annual operating profit margin is -67.03%

    Net Margin

    -31.86%
    BLRX annual net profit margin is -31.86%

    ROA & ROE

    ROA

    -17.93%
    BLRX annual return on assets is -17.93%

    ROE

    -69.11%
    BLRX annual return on equity is -69.11%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    BLRX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    BLRX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    0.71
    BLRX price to book ratio is 0.71

    PB Ratio Sector Percentile

    31.4%
    BLRX price to book ratio is higher than 31.4% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    0.82
    BLRX price to sales ratio is 0.82

    PS Ratio Sector Percentile

    20.34%
    BLRX price to sales ratio is higher than 20.34% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    -$1.36M
    BLRX enterprise value is -$1.36 million

    Enterprise Value Sector Percentile

    9.68%
    BLRX enterprise value is higher than 9.68% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.13
    BLRX EV/EBITDA is 0.13

    EV/EBITDA Sector Percentile

    64.47%
    BLRX EV/EBITDA is higher than 64.47% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    1.76
    BLRX annual current ratio is 1.76

    Quick Ratio

    1.56
    BLRX annual quick ratio is 1.56

    Leverage

    Debt To Equity

    1.12
    BLRX annual debt to equity ratio is 1.12

    Interest Coverage Ratio

    -
    BLRX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    3
    BLRX piotroski f-score is 3

    Altman Z-Score

    -14.59
    BLRX altman z-score is -14.59

    Analyst ratings

    Recent major analysts updates

    Jun 17, 25 HC Wainwright & Co.
    Buy
    May 30, 25 Jones Trading
    Buy
    May 28, 25 HC Wainwright & Co.
    Buy
    Apr 2, 25 Jones Trading
    Hold
    Mar 31, 25 HC Wainwright & Co.
    Buy
    Nov 25, 24 HC Wainwright & Co.
    Buy
    Nov 6, 24 HC Wainwright & Co.
    Buy
    Jun 3, 24 HC Wainwright & Co.
    Buy
    May 29, 24 HC Wainwright & Co.
    Buy
    Apr 17, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with BLRX included

    Growing Shares Outstanding
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for BioLineRx Ltd.?
    • Does BioLineRx Ltd. pay dividends?
    • What sector is BioLineRx Ltd. in?
    • What industry is BioLineRx Ltd. in?
    • What country is BioLineRx Ltd. based in?
    • When did BioLineRx Ltd. go public?
    • Is BioLineRx Ltd. in the S&P 500?
    • Is BioLineRx Ltd. in the NASDAQ 100?
    • Is BioLineRx Ltd. in the Dow Jones?
    • When was BioLineRx Ltd.'s last earnings report?
    • When does BioLineRx Ltd. report earnings?

    What is the ticker symbol for BioLineRx Ltd.?

    The ticker symbol for BioLineRx Ltd. is NASDAQ:BLRX

    Does BioLineRx Ltd. pay dividends?

    No, BioLineRx Ltd. does not pay dividends

    What sector is BioLineRx Ltd. in?

    BioLineRx Ltd. is in the Healthcare sector

    What industry is BioLineRx Ltd. in?

    BioLineRx Ltd. is in the Biotechnology industry

    What country is BioLineRx Ltd. based in?

    BioLineRx Ltd. is headquartered in Israel

    When did BioLineRx Ltd. go public?

    BioLineRx Ltd.'s initial public offering (IPO) was on July 27, 2011

    Is BioLineRx Ltd. in the S&P 500?

    No, BioLineRx Ltd. is not included in the S&P 500 index

    Is BioLineRx Ltd. in the NASDAQ 100?

    No, BioLineRx Ltd. is not included in the NASDAQ 100 index

    Is BioLineRx Ltd. in the Dow Jones?

    No, BioLineRx Ltd. is not included in the Dow Jones index

    When was BioLineRx Ltd.'s last earnings report?

    BioLineRx Ltd.'s most recent earnings report was on August 14, 2025

    When does BioLineRx Ltd. report earnings?

    The next expected earnings date for BioLineRx Ltd. is November 24, 2025
    On this page